CytoVas will work with Becton Dickinson to advance the development of a blood-based test that can be used to identify a person's risk for stroke and cardiovascular disease. The partnership will aid CytoVas in evaluating cardiovascular disease progression and complications tied to experimental and existing cardiovascular drugs.
CytoVas forges cardiovascular Dx partnership with Becton
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore